Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Long-term Investment Intensity
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Long-term Investment Intensity of 4.0% as of September 2019. Long-term investments of €2.18 Billion represent 4.0% of total assets of €54.32 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Guangzhou Baiyunshan Pharmaceutical Hold (GU5) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Long-term Investment Intensity (2013–2018)
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 4.0%, reflecting long-term investments of €2.18 Billion against total assets of €54.32 Billion EUR. Also explore Guangzhou Baiyunshan Pharmaceutical Hold asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see GU5 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.0% | €2.07 Billion | €51.48 Billion | ▼ -6.7 pp |
| 2017 | 10.8% | €3.05 Billion | €28.31 Billion | ▲ +0.7 pp |
| 2016 | 10.1% | €2.62 Billion | €25.90 Billion | ▼ -5.3 pp |
| 2015 | 15.4% | €2.44 Billion | €15.87 Billion | ▲ +0.8 pp |
| 2014 | 14.6% | €2.08 Billion | €14.27 Billion | ▼ -1.6 pp |
| 2013 | 16.2% | €1.99 Billion | €12.25 Billion | — |